Displaying 69 out of 275 Pharma companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Pheon Therapeutics HIRING

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

79
$120M · Series B TCG Crossover, Atlas Ventures, Brandon Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@pheontx.com
Causaly

Biomedical research discovery tool.

64
$60M · Series B ICONIQ Growth, Index Ventures, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
Apollo Therapeutics

Portfolio of pharmaceutical research and discovery.

64
$33M · Series C Patient Square Capital, Rock Springs Capital, M&G Investments 1 to 10 Biotech, Pharma London, UK •••••••••••@apollotherapeutics.com
Calluna Pharma

Developer of therapies for inflammatory and fibrotic diseases.

59
$81M · Series A Sarsia, p53, Forbion Capital Partners 11 to 50 Biotech, Pharma Oslo, Norway •••••••••••@callunapharma.com
ReViral

Biotechnology firm developing antiviral treatments for patients.

54
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
SafeHeal

Solution for protecting digestive anastomosis, designed to reduce complications.

54
$47M Sofinnova Partners 1 to 10 Health Tech, Hardware, Pharma, Manufacturing B2B Paris, France •••••••••••@safeheal.com
Flarin

Patent-protected anti-inflammatory painkiller.

54
$6M · Series A ITV AdVentures 1 to 10 Biotech, Pharma B2C London, UK •••••••••••@flarin.co.uk
ADmit Therapeutics

Early detection of Alzheimer's disease (AD) technology.

50
$5M · Series A WA4STEAM, EIC Accelerator, Ship2B 1 to 10 Health Tech, Biotech, Pharma B2B Barcelona, Spain •••••••••••@admit-therapeutics.com
Ariceum Therapeutics

Diagnosis and treatment of hard-to-treat cancers.

50
$24M · Series A Earlybird Venture Capital, Andera Partners, HealthCap 11 to 50 Health Tech, Biotech, Pharma B2B Berlin, Germany •••••••••••@ariceum-therapeutics.com
Bactolife

Producer of gut health binding proteins.

50
$32M · Series A Bill & Melinda Gates Foundation, Novo A/S 1 to 10 Biotech, Pharma B2B Copenhagen, Denmark •••••••••••@bactolife.com
Enterome

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

50
$3M · Series F The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Paris, France •••••••••••@enterome.com
Ermium Therapeutics

Biotech firm developing treatments for auto-immune diseases.

50
$6M · Series A Fountain Healthcare Partners 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@ermium.com
Hemab

Treatments for genetic bleeding disorders.

50
$135M · Series B Novo A/S, HealthCap 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Copenhagen, Denmark •••••••••••@hemab.com
Lyphe group

Supplier of medical cannabis care and medicine.

50
$6M · Series A Leafy Tunnel 51 to 100 Health Tech, Agritech, Pharma, Manufacturing, Cannabis B2B London, UK •••••••••••@LYPHEGROUP.com
Manual

Platform offering diagnostic tools and testing to aid patients in making health-related decisions.

50
$6M · Seed Felix Capital, Cherry Ventures, FJ Labs 11 to 50 Health Tech, Fashion, Pharma, Mobile, Ecommerce B2C London, UK •••••••••••@manual.co
Myricx Pharma

Drug discovery platform focused on developing small molecule inhibitors.

50
$6M · Seed Sofinnova Partners 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@myricxpharma.com
Pear Bio

Cancer treatment predictor software.

50
$14M · Series A Hoxton Ventures, Octopus Ventures, Fly Ventures 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@pearbio.com
Qubit Pharmaceuticals

Platform that accelerates drug discovery using advanced computational techniques.

50
$17M · Seed Quantonation, XAnge 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Paris, France •••••••••••@qubit-pharmaceuticals.com
Xund

We enable healthcare companies to digitize patient interactions and translate data into actionable insights.

50
$2M · Seed Thieme, MassMutual Ventures, MMC Ventures 11 to 50 Health Tech, AI, Insuretech, Pharma, Business Intelligence B2B, SaaS Vienna, Austria •••••••••••@xund.ai
Iktos

AI drug discovery platform.

50
$16M · Series A M Ventures 11 to 50 Pharma Paris, France •••••••••••@iktos.ai
BioVersys HIRING

Novel antiobiotic researcher to fight antimicrobial resistance.

46
$13M · Series C AMR Action Fund, GSK 1 to 10 Biotech, Pharma B2B Basel, Switzerland •••••••••••@bioversys.com
Aignostics

Platform that uses AI to improve diagnostics in pathology, aiding drug development and clinical research.

43
$5M · Seed High-Tech Gründerfonds, Ascension Ventures, Wellington Partners 11 to 50 Health Tech, AI, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Berlin, Germany •••••••••••@aignostics.com
Anjarium Biosciences

Gene therapy research to tackle genetic diseases.

43
$59M · Series A Gimv 1 to 10 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@anjarium.com
Castor EDC

Cloud-based clinical data platform.

43
$6M · Seed Eight Roads Ventures, Inkef Capital 101 to 250 Health Tech, Biotech, Pharma B2B, SaaS Amsterdam, Netherlands •••••••••••@castoredc.com
Charac

App that streamlines access to your local pharmacy, helping you skip the queue and manage prescriptions from anywhere.

43
$1M · Seed NPA, MedAdvisor 1 to 10 Pharma, Mobile, Ecommerce B2C, Marketplace London, UK •••••••••••@charac.co.uk
CimCure

Platform focused on designing and developing new active cancer immunotherapies.

43
$5M · Seed Positron Ventures Health Tech, Biotech, Pharma B2B Amsterdam, Netherlands •••••••••••@cimcure.com
Core Biogenesis

Biotechnology platform developing advanced recombinant protein production technologies.

43
$3M · Seed Entrepreneur First, Thia Ventures, XAnge 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Paris, France •••••••••••@corebiogenesis.com
Epsilogen

Immuno-oncology company treats cancer with antibodies.

43
$2M · Series A AlbionVC, Novartis Venture Fund, Epidarex Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics B2B London, UK •••••••••••@epsilogen.com
Gesynta Pharma

Developer of therapies for treating chronic inflammatory conditions.

43
$6M · Seed Industrifonden, Hadean Ventures 1 to 10 Health Tech, Pharma B2B Stockholm, Sweden •••••••••••@gesynta.se
HMNC Brain Health

Pioneer in precision medicine for psychiatry based in Munich.

43
$10M ALSTIN Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Munich, Germany •••••••••••@hmnc-brainhealth.com
Kayentis

Data capture for clinical trials.

43
$2M · Seed Bpifrance 11 to 50 Health Tech, Pharma, Data and Analytics B2B, SaaS Paris, France •••••••••••@kayentis.com
Peptone

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

43
$2M Hoxton Ventures, Bessemer Venture Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B London, UK •••••••••••@peptone.io
Precirix

Manufacturer of radio-immunotherapeutic drugs for cancer patients.

43
$40M · Series A Novo A/S, Forbion Capital Partners, BioMedPartners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Brussels, Belgium •••••••••••@precirix.com
Step Pharma

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

43
$2M · Seed Bpifrance, Idinvest Partners, AGORANOV 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@step-ph.com
NK:IO

Immunotherapy for the treatment of cancer.

43
$1M · Seed Cancer Research Horizons, UK Innovation & Science Seed Fund 11 to 50 Biotech, Pharma B2C London, UK •••••••••••@nk-io.com
VRG Therapeutics

Biotech R&D specializing in miniprotein-based pharmaceuticals and cellular & gene therapy (CGT) products

43
$5M · Series A Széchenyi Capital Fund Management 11 to 50 Biotech, Pharma Budapest, Hungary •••••••••••@vrgtherapeutics.com
Beckley Psytech

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

42
$40M · Series B Leafy Tunnel, ATAI Life Sciences 1 to 10 Biotech, Pharma B2C Oxford, UK •••••••••••@beckleypsytech.com
Amadix

Early cancer detection diagnostics platform.

39
$3M Inveready 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Madrid, Spain •••••••••••@amadix.com
apriwell

Solution against constipation using natural preparations.

39
$3M · Seed Calm/Storm Ventures 1 to 10 Health Tech, Foodtech, Pharma, Manufacturing B2B Berlin, Germany •••••••••••@apriwell.de
AptaTargets

Therapeutics treatment for strokes and brain injury.

39
$2M · Series A Caixa Capital Risc, Inveready 1 to 10 Health Tech, Biotech, Pharma B2B Madrid, Spain •••••••••••@aptatargets.com
Biosyntia

Biotech company specializing in synthetic biology and metabolic engineering.

39
$11M · Series B Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Copenhagen, Denmark •••••••••••@biosyntia.com
Devon Labs

Platform addressing patients' unmet medical and care needs.

39
$4M Inveready 1 to 10 Health Tech, Pharma B2B Madrid, Spain •••••••••••@devonlabs.com
Exogene

Biotechnology platform accelerating cancer cell therapy discoveries with AI-driven TCR-antigen screening.

39
$104k · Pre Seed Atomico, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics B2B London, UK •••••••••••@exogene.co.uk
GlycoEra

Glycanengineering platform.

39
$49M · Series A Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@glycoera.com
Inato

AI-powered data collecting tool for clinical trials.

39
$1M · Seed Kima Ventures, Cathay Innovation, Serena 11 to 50 Health Tech, AI, Biotech, Machine Learning, Pharma B2B, SaaS Paris, France •••••••••••@inato.com
Kither Biotech

Pharmaceutical developer specializing in new treatments for chronic inflammatory diseases.

39
$20M · Series B Claris Ventures, Tech4Planet 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Turin, Italy •••••••••••@kitherbiotech.com
Octarine Bio

Synthetic biology company producing superior cannabinoids for the pharmaceutical industry.

39
$4M · Series A The Footprint Firm, Unconventional Ventures, Oskare Capital 1 to 10 Health Tech, Biotech, Pharma, Manufacturing B2B Copenhagen, Denmark •••••••••••@octarinebio.com
Qualifyze

Platform ensuring transparent and secure supply chains in life sciences at affordable costs.

39
$12M · Series A HV Capital, Cherry Ventures, H14 11 to 50 AI, Pharma, Business Intelligence B2B, Marketplace Frankfurt, Germany •••••••••••@qualifyze.com
Rappta Therapeutics

Anti-cancer drugs ddevelopers activating protein phosphatase 2A (PP2A)

39
$10M · Series A Novo A/S, Novartis Venture Fund 1 to 10 Health Tech, Biotech, Pharma B2B Helsinki, Finland •••••••••••@rappta-therapeutics.com
Tuli Health

Digital health platform providing instant access to private medical appointments and testing.

39
$125k · Pre Seed Y Combinator 1 to 10 Health Tech, CPG & Consumer Goods, Pharma B2B, SaaS London, UK •••••••••••@tuli.health
XO Life

Platform that connects patients and pharmaceutical companies to improve health outcomes.

39
$2M · Seed Aescuvest 11 to 50 Health Tech, Pharma, Sales and Marketing B2B, Marketplace Munich, Germany •••••••••••@xo-life.com
Phlo HIRING

Digital pharmacy platform.

39
$180k · Seed Scottish Investment Bank, Par Equity 51 to 100 Pharma B2C, SaaS London, UK •••••••••••@wearephlo.com
Actimed Therapeutics

Developer of innovative treatment for muscle wasting disorders.

39
$1M · Seed Mankind Pharma 1 to 10 Biotech, Pharma London, UK •••••••••••@actimedtherapeutics.com
Measurlabs

Testing and certifications platform for any material, product or chemical.

39
$2M · Seed VentureFriends, Lifeline Ventures 11 to 50 Biotech, Pharma Helsinki, Finland •••••••••••@measurlabs.com
AbolerIS Pharma

Therapeutic platform focused on developing treatments that promote immune tolerance.

37
$29M · Series A Caixa Capital Risc, Sound Bioventures 1 to 10 Health Tech, Biotech, Pharma B2B Nantes, France •••••••••••@aboleris-pharma.com
Cardior Pharmaceuticals

Platform for discovering and developing medicines to treat and prevent heart disease.

37
$76M BioMedPartners, High-Tech Gründerfonds, Inkef Capital 11 to 50 Health Tech, Biotech, Pharma B2B Hanover, Germany •••••••••••@cardior.de
Emergence Therapeutics

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

37
$99M High-Tech Gründerfonds, Hadean Ventures 1 to 10 Health Tech, Biotech, Pharma, Fitness, Manufacturing B2B Duisburg, Germany •••••••••••@emergencetx.com
F2G

Platform discovering and developing new drugs to treat severe fungal diseases.

37
$70M Sofinnova Partners, Novo A/S, Forbion Capital Partners 251 to 500 Health Tech, Biotech, Pharma, Genetics B2B Manchester, UK •••••••••••@f2g.com
Healx

Platform for discovering new drugs for rare diseases using AI technology.

37
$56M · Series B Balderton Capital, Atomico, btov Partners 51 to 100 Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Cambridge, UK •••••••••••@healx.io
ImCheck Therapeutics

Platform developing new treatments that focus on the butyrophilin family's checkpoint molecules.

37
$102M Earlybird Venture Capital, Eurazeo, Andera Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Marseille, France •••••••••••@imchecktherapeutics.com
Noema Pharma

Clinical-stage central nervous system (CNS) technology.

37
$110M · Series B Sofinnova Partners, Forbion Capital Partners, BioMedPartners 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@noemapharma.com
Osler Diagnostics

Lab-quality diagnostics for anyone, anywhere, at any time.

37
$85M Oxford Science Enterprises 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Oxford, UK •••••••••••@oslerdiagnostics.com
Oxford Nanopore Technologies

Platform for analyzing single molecules like DNA, RNA, and proteins using nanopore-based electronic systems.

37
$275M Wellington Management 251 to 500 Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics B2B Oxford, UK •••••••••••@nanoporetech.com
Alex Therapeutics

AI-powered CBT therapeutic platform.

34
$130k · Pre Seed Scale Capital, Hadean Ventures, Sweet Studio 1 to 10 Health Tech, AI, Pharma, Ecommerce B2B, Marketplace Stockholm, Sweden •••••••••••@alextherapeutics.com
Climedo

Platform for clinical validation and product surveillance of medical devices and pharmaceutical products.

34
$1M · Pre Seed Nauta Capital 51 to 100 Health Tech, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Munich, Germany •••••••••••@climedo.de
Fermify

Casein protein manufacturer for animal-free cheese.

34
$5M · Seed Climentum Capital, PUSH Ventures, BackBone Ventures 1 to 10 Foodtech, Biotech, Pharma, Manufacturing B2B Vienna, Austria •••••••••••@fermify.org
Hemispherian

Pre-clinical platform for all kinds of cancer treatment.

34
$3M Investinor 1 to 10 Health Tech, Biotech, Pharma B2B Oslo, Norway •••••••••••@hemispherian.com
Inossia

Softener that improves bone cements to match the mechanical properties of osteoporotic bone.

34
$330k · Pre Seed Almi Invest 1 to 10 Health Tech, Hardware, Pharma B2B Stockholm, Sweden •••••••••••@inossia.com
MiNA Therapeutics

Biotechnology company focused on developing therapeutic medicines by harnessing gene activation mechanisms.

34
$29M 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Genetics B2B London, UK •••••••••••@minatx.com
OTHER INDUSTRIES
Other Pharma startups by location